John Timpson CBE
Read the oration for John Timpson OBE on the award of their Honorary Fellowship from Liverpool John Moores University presented by Professor Frank Sanderson.
Read the oration for John Timpson OBE on the award of their Honorary Fellowship from Liverpool John Moores University presented by Professor Frank Sanderson.
Develop adult congenital heart disease care skills at LJMU, supporting patients across the lifespan and specialist services. | Apply now for 2026 entry
The Exhibition Research Lab is the first centre devoted to the study of exhibitions. We have ties with Tate Liverpool, the Liverpool Biennial, as well as six major European museums and a network of arts institutions. Find out more about the Lab's collaborations and projects.
The key success of the Business, Corporate, Banking and Finance Law Research Group was its contribution to the corporate governance and financial regulation debate during the global financial crisis. The Group's areas of expertise include banking and financial regulation, corporate governance, professional and business ethics, and regulatory risk management and compliance.
View the current PhD projects within the Research Centre in Evolutionary Anthropology and Palaeoecology to find out the type of work our PhD students undertake. Plus, find out how to apply for a PhD within the Centre.
Read the oration for The Rt Revd James Jones on the award of their Honorary Fellowship from Liverpool John Moores University presented by Professor Lord Alton.
The Royal British Legion was founded in 1921 by British veterans in the aftermath of the First World War.
Find out more about LJMU's Masters Level Certificate in Independent Prescribing for Pharmacists.
A collaboration across institutions and countries capturing the cultural, social and economic transformations of the European Capital of Culture 2026 in Trenčín, Slovakia.
The Vaccine Lounge: Bridging Hesitancy and Innovation in Vaccine Policy project will strengthen international collaboration between researchers and policymakers in the UK, Uganda, Kenya, and Burkina Faso to address pressing challenges in vaccine development and uptake, with a focus on emerging mRNA technologies.